(571) 447-5500

FDA Initiates Review of BHA, a Common Food Preservative

FDA Guidance Update

The U.S. Food and Drug Administration has announced that it is launching a safety assessment of butylated hydroxyanisole (BHA), a synthetic antioxidant widely used in food products to prevent rancidity in fats and oils.

BHA has been authorized for use in food for decades within established regulatory limits. FDA stated that this review is part of its broader initiative to reassess food chemicals using updated scientific methodologies and current exposure data.

What This Assessment Involves

According to the Agency, the evaluation will consider:

  • Existing toxicological data
  • Estimated dietary exposure levels
  • New scientific literature
  • Current approved conditions of use

At this time, FDA has not proposed changes to BHA’s regulatory status. The announcement reflects an evaluation process rather than a determination of risk.

Context Within FDA’s Modernization Efforts

FDA has recently signaled increased focus on reviewing legacy food additives and preservatives under updated risk assessment frameworks. The reassessment of BHA aligns with this broader effort to ensure that existing authorizations continue to meet contemporary scientific standards.

Considerations for Food Manufacturers

Companies that utilize BHA in formulations should:
  • Confirm usage remains within regulatory limits
  • Maintain current safety documentation and supplier certifications
  • Monitor FDA communications for potential updates
  • Consider long-term formulation planning if future changes are proposed
EAS will continue tracking FDA’s review process and provide updates should regulatory action or guidance follow.

Source: FDA News Release

Date: February 10, 2026

Posted in FDA and USDA Regulatory Update, Foods.